Delivery Order SPE2DR25D9202-SPE2DR26FHBR7
Award Date 3/11/26
Potential Completion Date 3/12/26
Potential Value $1.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, for lidocaine 5% patch 30-count units, with a ceiling value of $1,582.00. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, for Lidocaine 5% Patch 30S with a ceiling value of $3,045.50, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications,...
- The Defense Logistics Agency issued a $2,192.76 delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for Lidocaine 5% Patch 30s. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group Inc....
- The Defense Logistics Agency issued a $1,461.84 delivery order to DMS Pharmaceutical Group Inc. on February 20, 2026, for Lidocaine 5% Patch 30s under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency issued a $2,192.76 delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for lidocaine 5% patch 30-count units. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. Place of performance is Park...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 20, 2026, for $21,927.60 to supply Lidocaine 5% Patch 30s, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. The parent IDC, awarded to...
- The Defense Logistics Agency issued a $3,654.60 delivery order to DMS Pharmaceutical Group Inc. on February 27, 2026, for Lidocaine 5% Patch 30s under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the Defense Logistics Agency's PPV-G GEN V indefinite delivery contract, a $499.999 billion program supporting pharmaceutical supply to Department of Defense healthcare facilities...
- <p>The Defense Logistics Agency issued a $3,383.08 delivery order to DMS Pharmaceutical Group Inc. on March 11, 2026, for Lidocaine 5% Patch 30s under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, Illinois. The order carries a firm fixed-price structure with an ultimate completion date of March 12, 2026.</p>
- The Defense Logistics Agency awarded a delivery order valued at $3,796.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30S. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 15, 2025, and no set-aside designation was utilized. Performance will take place in Park Ridge, Illinois, with funding provided by the Defense...
- The Defense Logistics Agency awarded a $1,461.84 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30S. The award, issued on January 27, 2026, with an ultimate completion date of January 28, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued...